Hi everyone! welcome to the next episode of FINtastic Talks.
We thank you for your love which has led us to 1.3 million views and is a testimony of your affection for the show. We are grateful for your trust in us, and we believe that we are contributing to building your second income or a second version of yourself which is the passive income that becomes big one day and can support you in the current as well as in the future times.
It might not be apparent, but there is a big difference between being rich and wealthy. A person earning a crore rupees per month and with an expenditure of Rs.10 lacs with no fresh income is going to be broke in 10 months, while if a person has a source to refurbish this income and invest properly has the capacity to live through the lifetime. People also come up with queries and apprehensions like I find it too daunting to manage investments, so my advice to them is - “If you are sitting on the fence, you’ll never win the race,” and this lag can be bridged with a specialized education program we are offering called “FINtastic”, so guys go for it and win the race.
And now, we welcome our special guest from the Life Insurance sector, Mr.Satishwar Balakrishnan, MD and CEO at Aegon Life, and begin a very interesting talk because Aegon is a Digital-First Life Insurance company. So welcome, Satishwar.
If you are sitting on the fence, you’ll never win the race.-Sanjiv Bajaj
Q. Sanjiv Bajaj- So, Satishwar, we want to know you as a person, about your education, your childhood, how did you get into this industry, your journey and all.
This story is from the December 2022 edition of Investors India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 2022 edition of Investors India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
A Doctor Within You: Your Immune System
The fact that you survive is due to your immune system-a fascinating network of chemicals and cells that protect your body.
PERSON OF THE YEAR 2024
Like every year there were many contenders. Don is back dodging bullets by the ear. He can claim the year. Criminal convictions?
Indian Mutual Fund Industry in 2025 What Lies Ahead?
Q. How do you view the performance of the MF industry, in general, and your fund house, in particular, during 2024?
Add Health to Your Wealth
Life is unpredictable because it is influenced by countless unpredictable factors such as accidents, illness, economic changes, natural disasters or personal circumstances.
Market strategy for the year 2025
India’s GDP print came in lower than expectations at 5.4% substantially lower than 6.7% recorded in Q1 FY’25 and 8.1% in Q2 FY’24 seems mainly by a slowdown in government expenditure and capital formation.
Review and Rebalance Your Portfolio at the Start of 2025
At the start of 2025, investors must review their investment portfolios and bring about certain changes to prepare them for the challenges of the new year. Let us begin by reviewing the year that has gone by, and then discuss the changes you need to make to your portfolio.
An Overview on Asset Allocation
The recent sharp volatility in the stock markets has retail investors worried, especially those who put all their funds into equity and completely ignored fixed income/debt and gold.
Indians are Developing Weak Bones
In India, 1 out of 8 males and 1 out of 3 females suffer from osteoporosis, making India one of the largest affected countries in the world.
"The strategy behind the Tata India Innovation Fund centers on identifying companies that are driving transformative or incremental changes through innovation"
Yes, we certainly believe innovation is a powerful theme with immense potential for the coming years, and we are excited to bring it to our investors.
What is Hybrid Mutual Fund?
Hybrid Mutual Fund is a combination of more than one type of fund. While they invest in shares of companies listed on the exchange, like equity funds.
